ABOUT BAPA

Our Mission

Advocate – Educate – Communicate

We strive to organize Bangladeshi-American Pharmacists in a strong and professional platform so they can be more successful in their career and have a fulfilling experience in this country. We work to get the members involved in the socio-political process that determines their future. We hope to motivate everyone to contribute their time and talent to the betterment of the pharmacy profession here at home and in Bangladesh.

Specifically, the purpose of the organization is to foster cooperation and collaboration among Bangladeshi pharmacists residing in North America; to build and maintain relations with other pharmacists’ associations in North America, to support the profession of pharmacy in Bangladesh and in North America; to support and encourage the development of Pharmaceutical Science in Bangladesh; to develop and conduct programs for maintaining and improving the professional standards; to promote welfare of members’ families in case of need; to protect the professional interests of members of the Association.

Our Sponsors

Silver Sponsor

Silver Sponsor

Silver Sponsor

Pharmaceutical News

  • Researchers discover Achilles' heel of antibiotic-resistant bacteria
    on October 23, 2026 at 8:00 am

    Even highly antibiotic-resistant bacteria become more vulnerable when their cell wall transport system is disrupted, according to a new study from Umeå University in Sweden. The discovery reveals a previously overlooked weakness that could help researchers develop new strategies to combat antibiotic resistance. “The search for new antibiotics remains crucial, but we also need smarter ways to extend the lifespan of the antibiotics we already have.

  • Lactation drug could reduce breast cancer risk after childbirth
    on October 22, 2026 at 8:00 am

    An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth. Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few side effects. But it may also offer unexpected benefits.

  • Google.org awards $2.3 million USD to University of Toronto researchers to advance AI-powered peptide drug discovery
    on October 21, 2026 at 8:00 am

    A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential. The project is funded through the Google.org Impact Challenge: AI for Science initiative. The newly funded initiative, OpenPep, will lead to an open access database that will allow researchers to use artificial intelligence (AI) to predict which peptides will bind to target proteins.

  • FDA issues final guidance on Prescription drug apps and software
    on October 20, 2026 at 8:00 am

    The U.S. Food and Drug Administration today released final guidance establishing a clear framework for how drug companies can develop, distribute, and label apps used alongside their prescription medicines. The guidance ends longstanding uncertainty by providing recommendations about when app content is subject to FDA submission requirements, when an app should be mentioned on a drug’s official label, and what companies should submit to the agency.

  • Unsuspected discovery of abnormal antibodies could explain pediatric cancer
    on October 19, 2026 at 8:00 am

    A team of scientists in Norway has found evidence for a new, previously unknown mechanism for the development of cancer in children: they seem to produce an unusual amount of aberrant antibodies against the building blocks that make up the DNA repair machinery, a diverse set of hundreds of proteins which identify and correct damage or errors in the genome. This important discovery could open the door to the early screening of small children, in the hope of ultimately preventing them from developing such pediatric cancers years in their teenage years.